NCI | Technology Transfer

CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON

Read more about CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON

US Patent 11,718,861
Filed on 2020-12-14

ANTI-THYROGLOBULIN T CELL RECEPTORS

Read more about ANTI-THYROGLOBULIN T CELL RECEPTORS

European Patent
20208238.4
Filed on 2020-11-17

THALIDOMIDE ANALOGS AND METHODS OF USE

Read more about THALIDOMIDE ANALOGS AND METHODS OF USE

US Patent 11,440,880
Filed on 2020-10-29

Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor

Read more about Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor

Japan
2020-182208
Filed on 2020-10-30

T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Norway
18175738.6
Filed on 2018-06-04

T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Turkey
18175738.6
Filed on 2018-06-04

T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Slovakia
18175738.6
Filed on 2018-06-04

T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Slovenia
18175738.6
Filed on 2018-06-04

T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Sweden
18175738.6
Filed on 2018-06-04

T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage

Portugal
18175738.6
Filed on 2018-06-04

Subscribe to NCI